Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production

Condition:   Adrenocortical Carcinoma Interventions:   Drug: Relacorilant;   Drug: Pembrolizumab Sponsor:   Corcept Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials